SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018513
Filing Date
2020-04-24
Accepted
2020-04-24 16:16:23
Documents
7
Period of Report
2020-06-04
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A cnst-def14a_20200604.htm DEF 14A 937174
2 GRAPHIC ghfmfopkzybf000001.jpg GRAPHIC 3981
3 GRAPHIC ghfmfopkzybf000002.jpg GRAPHIC 2149
4 GRAPHIC ghfmfopkzybf000005.jpg GRAPHIC 65819
5 GRAPHIC ghfmfopkzybf000003.jpg GRAPHIC 3981
6 GRAPHIC ghfmfopkzybf000006.jpg GRAPHIC 36088
7 GRAPHIC ghfmfopkzybf000004.jpg GRAPHIC 1868
  Complete submission text file 0001564590-20-018513.txt   1096025
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38584 | Film No.: 20815148
SIC: 2834 Pharmaceutical Preparations